Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!
cyber monday sale cyber monday sale

81% in COVID-19 Vaccine Trial With Human Fetal Cell Line Suffer Adverse Reactions

  • July 07, 2020

A Chinese COVID-19 vaccine clinical trial is reporting early results that show 81% of the participants suffered at least one adverse reaction within seven days after vaccination. The trial, developed by CanSino Biologics, uses cell lines from an aborted human fetus, along with a chimpanzee adenovirus vector. Canada’s National Research Council is also using the human cell line for its COVID-19 vaccine candidates. Adverse reactions reported so far with CanSino’s vaccine range...